SCHEMBL31507488

SCHEMBL31507488

NC(=O)c1cc(-c2ccns2)cc(Cl)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.42
▸ MAPK14 Q16539 2/20 0.39
▸ MAP2K3 P46734 1/20 0.39
▸ CCNC P24863 1/20 0.34
▸ CDK8 P49336 1/20 0.34
▸ GRM2 Q14416 5/20 0.33
▸ SIRT6 Q8N6T7 1/20 0.33
▸ PIM1 P11309 4/20 0.33
▸ PIM3 Q86V86 3/20 0.33
▸ AURKA O14965 1/20 0.33
▸ JAK2 O60674 1/20 0.33
▸ NTRK1 P04629 1/20 0.33
▸ RET P07949 1/20 0.33
▸ FGFR1 P11362 1/20 0.33
▸ PRKACA P17612 1/20 0.33
▸ LTK P29376 1/20 0.33
▸ KDR P35968 1/20 0.33
▸ MAP2K2 P36507 1/20 0.33
▸ FLT3 P36888 1/20 0.33
▸ MAPK8 P45983 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26684723 1.00 LMNA (0.42) LMNAMAPK14MAP2K3CCNCCDK8
SCHEMBL26852028 0.82 MAPK14 (0.39) LMNAMAPK14MAP2K3CCNCCDK8
SCHEMBL26684326 0.73 CHEK1 (0.44) LMNAGRM2SIRT6GSK3B
SCHEMBL31507550 0.73 CHEK1 (0.44) LMNAGRM2SIRT6GSK3B
SCHEMBL30667773 0.71 LMNA (0.40) LMNAPIM1PIM3PIM2SCN9A
SCHEMBL26863020 0.71 LMNA (0.40) LMNAPIM1PIM3PIM2SCN9A
SCHEMBL28205638 0.69 MKNK1 (0.49) MAPK14MAP2K3CYP1A2CYP3A4CYP2D6
SCHEMBL11616643 0.68 LMNA (0.59) LMNAGRM2SIRT6PIM1PIM3
SCHEMBL30097621 0.68 LMNA (0.59) LMNAGRM2SIRT6PIM1PIM3
SCHEMBL23413330 0.67 LMNA (0.57) LMNAGRM2SIRT6PIM1PIM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119546602-A Pyrrolidone derivatives as inhibitors of nfkb-induced kinase 詹森药业有限公司 2025-02-28 — — CN disclosed
Send feedback